Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Saurabh Chhabra, MD, Parameswaran Hari, MD MRCP, MS, Alexis Visotcky, Nirav N Shah, MD, J. Douglas Rizzo, MD, Wael Saber, MD MS, Anita D'Souza, MBBS, Binod Dhakal, MBBS, Ashish Anshu, MS, PhD, Robert Thompson, Timothy S. Fenske, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, William R. Drobyski, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD

Blood (2017) 130 (Supplement 1): 1974.

https://doi.org/10.1182/blood.V130.Suppl_1.1974.1974

Published: 2017

Journal Articles

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Anita D'Souza, MBBS, Heather R. Millard, MPH, Jennifer Knight, MD, Ruta Brazauskas, PhD, Jenny Vogel, Deborah Mattila, Kathryn Flynn, PhD, Stephanie J Lee, MD MPH, Mary M. Horowitz, MD MS, J. Douglas Rizzo, MD, Bronwen E. Shaw, PhD MRCP, FRCPath

Blood (2017) 130 (Supplement 1): 3447.

https://doi.org/10.1182/blood.V130.Suppl_1.3447.3447

Published: 2017

Journal Articles

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Ehab Atallah, MD, Mary M. Horowitz, MD MS, Brent Logan, PhD, Min Chen, MS, Michael J. Boo, JD, Corey S Cutler, MD MPH, Joachim Deeg, MD, James L. Gajewski, MD, Dennis L. Confer, MD, Stephanie Farnia, MPH, Peter Greenberg, MD, Erica Warlick, MD, Daniel Weisdorf, MD, J. Douglas Rizzo, MD

Blood (2015) 126 (23): 193.

https://doi.org/10.1182/blood.V126.23.193.193

Published: 2015

Journal Articles

Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

William A. Wood, MD MPH, Jennifer Le-Rademacher, PhD, Mingwei Fei, MS, Brent R. Logan, PhD, Karen L Syrjala, PhD, Navneet S. Majhail, MD MS, John R. Wingard, MD, Muneer H. Abidi, MD, Nancy L. Geller, PhD, Juan Wu, MS, J. Douglas Rizzo, MD, Edward A Faber, DO, MS, Heather Jim, PhD, Paul Jacobsen, PhD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD MPH

Blood (2014) 124 (21): 206.

https://doi.org/10.1182/blood.V124.21.206.206

Published: 2014

Journal Articles

Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts

Matthew D. Seftel, MDMPH FRCPC, Donna Neuberg, ScD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Julie Bergeron, MD FRCPC, Stephen Couban, MD FRCPC, Daniel J. DeAngelo, MD PhD, Marcos J de Lima, MD, Steven M. Devine, MD, Mary Eapen, MBBS, Mary M. Horowitz, MD MS, Marcelo C. Pasquini, MD MS, J. Douglas Rizzo, MD, Wael Saber, MD MS, Stephen E. Sallan, Brenda M. Sandmaier, MD, Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 319.

https://doi.org/10.1182/blood.V124.21.319.319

Published: 2014

Journal Articles

Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe)

Michael A. Pulsipher, MD, Brent R. Logan, PhD, Deidre M. Kiefer, MPH, Pintip Chitphakdithai, PhD, Galen E. Switzer, PhD, Marcie L Riches, MD MS, J. Douglas Rizzo, MD, Paolo Anderlini, MD, Susan F. Leitman, James W Varni, PhD, Amy Hays, MPH, RN, Hati Kobusingye, MS, RaeAnne M. Besser, John P. Miller, MD PhD, Rebecca J. Drexler, BS, Roberta J. King, MPH, Mary M. Horowitz, MD MS, Willis H. Navarro, MD, Dennis L. Confer, MD

Blood (2014) 124 (21): 3847.

https://doi.org/10.1182/blood.V124.21.3847.3847

Published: 2014

Journal Articles

Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR)

Navneet S. Majhail, MD, MS, Tammy Payton, BS, Lih-Wen Mau, PhD, MPH, Jennifer Le Rademacher, PhD, Pintip Chitphakdithai, PhD, Michael Eckrich, MD, Steven Joffe, MD, MPH, Stephanie J. Lee, MD, MPH, Charles F. LeMaistre, MD, Fausto R. Loberiza, Jr., MD, MS, Brent R. Logan, PhD, Elizabeth A Murphy, RN, ScD, Susan K. Parsons, MD, MRP, Ramona Repaczki-Jones, J. Douglas Rizzo, MD, Pam Robinett, Ellen Denzen, MS

Blood (2013) 122 (21): 1687.

https://doi.org/10.1182/blood.V122.21.1687.1687

Published: 2013

Journal Articles

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

Philippe Armand, MD, PhD, Haesook T. Kim, PhD, Brent R. Logan, PhD, Zhiwei Wang, MS, Edwin P. Alyea, MD, Matt Kalaycio, MD, Richard T. Maziarz, MD, Joseph H. Antin, MD, Robert J Soiffer, MD, Daniel J. Weisdorf, MD, J. Douglas Rizzo, MD, Mary M. Horowitz, MD, MS, Wael Saber, MD, MS

Blood (2013) 122 (21): 548.

https://doi.org/10.1182/blood.V122.21.548.548

Published: 2013

Journal Articles

Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

Stephanie J. Lee, MD, MPH, Jennifer Le Rademacher, PhD, Heather Jim, PhD, Karen L Syrjala, PhD, John R. Wingard, MD, PhD, Brent R. Logan, PhD, Juan Wu, MS, Navneet S. Majhail, MD, MS, William A. Wood, MD, MPH, J. Douglas Rizzo, MD, Nancy L. Geller, PhD, Carrie L. Kitko, MD, Edward A. Faber, Jr., DO, MS, Muneer H. Abidi, MD, Susan E. Slater, FNP, Mary M. Horowitz, MD, MS, Paul Jacobsen, Ph.D.

Blood (2013) 122 (21): 699.

https://doi.org/10.1182/blood.V122.21.699.699

Published: 2013

Journal Articles

Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Wael Saber, MD, MS, Corey Cutler, MD, MPH, FRCPC, Ryotaro Nakamura, MD, Mei-Jie Zhang, PhD, Ehab Atallah, MD, J. Douglas Rizzo, MD, MS, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Matt Kalaycio, MD, Mary M. Horowitz, MD, MS

Blood (2012) 120 (21): 355.

https://doi.org/10.1182/blood.V120.21.355.355

Published: 2012

Journal Articles

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

Ehab Atallah, MD, Tanya L. Pedersen, MPH, Erica D. Warlick, MD, Anne Dircks, BS, CCRP, Daniel Weisdorf, MD, Mary M. Horowitz, MD, MS, J. Douglas Rizzo, MD

Blood (2012) 120 (21): 1983.

https://doi.org/10.1182/blood.V120.21.1983.1983

Published: 2012

Journal Articles

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Michael J Eckrich, MD, MPH, Jennifer Le-Rademacher, PhD, J. Douglas Rizzo, MD, MS, K. Scott Baker, MD, MS, Deepika Bhatla, MD, David K. Buchbinder, M.D., M.S.H.S., Kenneth R. Cooke, MD, Reggie Duerst, MD, Andrew Gilman, MD, Haydar Frangoul, MD, Neena Kapoor, MD, Nancy A. Kernan, MD, Michael Verneris, MD, Mary Eapen, MBBS

Blood (2012) 120 (21): 762.

https://doi.org/10.1182/blood.V120.21.762.762

Published: 2012

Journal Articles

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Marcelo C. Pasquini, MD, MS, Brent R. Logan, PhD, Vincent T Ho, MD, Philip L. McCarthy, Jr., MD, Kenneth R. Cooke, MD, J. Douglas Rizzo, MD, Xiaochun Zhu, MS, Mohamed L. Sorror, MD, MSc

Blood (2012) 120 (21): 814.

https://doi.org/10.1182/blood.V120.21.814.814

Published: 2012

Journal Articles

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

Mohamed L. Sorror, MD, MSc, Brent R. Logan, PhD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Kenneth R. Cooke, MD, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Barry Storer, PhD, Marcelo C Pasquini, MD, MS

Blood (2012) 120 (21): 733.

https://doi.org/10.1182/blood.V120.21.733.733

Published: 2012

Journal Articles

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

Monica S Thakar, MD, Brent R. Logan, PhD, Marcelo C. Pasquini, MD, MS, Philip L. McCarthy, Jr., MD, Vincent T Ho, MD, Kenneth R. Cooke, MD, Xiaochun Zhu, MS, J. Douglas Rizzo, MD, Mohamed L. Sorror, MD, MSc

Blood (2012) 120 (21): 737.

https://doi.org/10.1182/blood.V120.21.737.737

Published: 2012

Journal Articles

The Value of the Hematologist: Appropriate Use of Diagnostic Endoscopy in Microcytic and Normocytic Anemias (MNA)

Vincent Picozzi, MD, MMM, Jeanae Releford, BS, Margaret Faure, BS, Daniel Eastwood, MS, J. Douglas Rizzo, MD, MS

Blood (2011) 118 (21): 342.

https://doi.org/10.1182/blood.V118.21.342.342

Published: 2011

Journal Articles

Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning

Daniel J. Weisdorf, MD, Mei-Jie Zhang, PhD, Mukta Arora, MD, J. Douglas Rizzo, MD MS, Mary M. Horowitz, MD, Mary Eapen, MBBS

Blood (2011) 118 (21): 1014.

https://doi.org/10.1182/blood.V118.21.1014.1014

Published: 2011

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).

Blood (2010) 116 (21): 3486.

https://doi.org/10.1182/blood.V116.21.3486.3486

Published: 2010

Journal Articles

Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Theresa Hahn, PhD, Philip L. McCarthy, MD, Anna Hassebroek, MPH, John P. Klein, PhD, J. Douglas Rizzo, MD, MS, Susan Parsons, MD, MRP, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2010) 116 (21): 3509.

https://doi.org/10.1182/blood.V116.21.3509.3509

Published: 2010

NARROW

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Outcome of Patients 65 Years and Older with Myelodysplastic Syndrome (MDS) Receiving Allogeneic Hematopoietic Stem Cell Transplantation Compared to Patients 55-64 Years of Age

Patient-Reported Quality of Life Is an Independent Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation: A Secondary Analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

Superiority of Pediatric Chemotherapy over Allogeneic Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult ALL in First Complete Remission: A Combined Analysis of Dana-Farber ALL Consortium and CIBMTR Cohorts

Baseline Symptoms, Female Sex, and Younger Age Are Correlated with Higher Levels of Peri-Collection Pain, Symptoms, and Persistent Discomfort One Year after Related Donor BM and PBSC Donation: An Analysis of the Related Donor Safety Study (RDSafe)

Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR)

Validation and Refinement Of The Disease Risk Index For Stratification Of Patients Undergoing Allogeneic Stem Cell Transplantation: A Study Of 13,131 Patients From The Center For International Blood & Marrow Transplant Research

Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Comorbidity Index (CI) in Autologous Hematopoietic Cell Transplantation (HCT) for Malignant Diseases: Validation of the HCT-CI

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) for HCT Outcomes At US Transplant Centers: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study

The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Can Prospectively Discriminate Risks Affecting Overall Survival in Pediatric and Adult Patients with Non-Malignant Diseases

The Value of the Hematologist: Appropriate Use of Diagnostic Endoscopy in Microcytic and Normocytic Anemias (MNA)

Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).

Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only